Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 25Unknown 5Terminated 2Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 36Gastrointestinal 16Breast 9Sarcoma 6Dermatologic 4CNS 4Other hematologic neoplasm 3Lymphoid 3Tumor-Agnostic 2Thoracic 2Other solid neoplasm 2NET 2Myeloid 2Head & Neck 2Endocrine 2Plasma cell 1Classical hematology 1

Conditions

Small Cell Lung Carcinoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 158Pemetrexed 135Cisplatin 115pembrolizumab 99Docetaxel 94Paclitaxel 89Gemcitabine 63Erlotinib Hydrochloride 60Radiotherapy 55Nivolumab 55Bevacizumab 46Etoposide 42atezolizumab 33Radiosurgery 33durvalumab 28Cyclophosphamide 22Vinorelbine 21Ipilimumab 21Radiation 20Taxes 17130-nm albumin-bound paclitaxel 17Albumin-Bound Paclitaxel 16Gefitinib 14Irinotecan 13Drug Therapy 13osimertinib 12avelumab 12Magnetic Resonance Spectroscopy 12Dexamethasone 12Cetuximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Sunitinib × Thoracic × Clear all
NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
9 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00434226 2009-08-21

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Genentech, Inc.

Phase 2 Terminated
56 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡